Osteoarthritis in Pulmicort - how severe and when it was recovered? (a real world drug study)

Summary:

We study how severe was Osteoarthritis, when it was recovered, drug effectiveness, race, and more among people who take Pulmicort (budesonide). This phase IV clinical study is created by eHealthMe based on reports submitted to eHealthMe, and is updated regularly.

What is Pulmicort?

Pulmicort has active ingredients of budesonide. It is often used in asthma. eHealthMe is studying from 34,980 Pulmicort users. Check the latest studies of Pulmicort.

What is Osteoarthritis?

Osteoarthritis (a joint disease caused by cartilage loss in a joint) is found to be associated with 1,878 drugs and 2,647 conditions by eHealthMe. Check the latest studies of Osteoarthritis.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.



On Jun, 27, 2026

2 people who have Osteoarthritis while taking Pulmicort were studied.

Could Pulmicort cause Osteoarthritis?

Severity of Osteoarthritis *:

  • least: 50 %
  • moderate: 0.0 %
  • severe: 50 %
  • most severe: 0.0 %

When people recovered from Osteoarthritis *:

  • while on drug: 0.0 %
  • after off the drug: 0.0 %
  • not yet: 100 %

Effectiveness of Pulmicort *:

  • not at all: 0.0 %
  • somewhat: 0.0 %
  • moderate: 0.0 %
  • high: 100 %
  • very high: 0.0 %

Race of the people *:

  • African American, Non-Hispanic: 0.0 %
  • American Indian/Alaska Native: 0.0 %
  • Asian: 0.0 %
  • Hispanic: 0.0 %
  • Native Hawaiians/Pacific Islanders: 0.0 %
  • Two or more races: 0.0 %
  • White, Non-Hispanic: 100 %

Time on Pulmicort *:

  • < 1 month: 0.0 %
  • 1 - 6 months: 50 %
  • 6 - 12 months: 0.0 %
  • 1 - 2 years: 50 %
  • 2 - 5 years: 0.0 %
  • 5 - 10 years: 0.0 %
  • 10+ years: 0.0 %

Gender of people when taking Pulmicort *:

  • female: 100 %
  • male: 0.0 %

Age of people when taking Pulmicort *:

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 0.0 %
  • 20-29: 0.0 %
  • 30-39: 50 %
  • 40-49: 0.0 %
  • 50-59: 0.0 %
  • 60+: 50 %

Conditions people have *:

  1. Sinusitis (inflammation of sinus): 1 person, 50.00%
  2. Osteoporosis (bones weak and more likely to break): 1 person, 50.00%
  3. Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 1 person, 50.00%
  4. Constipation: 1 person, 50.00%
  5. Allergic Rhinitis: 1 person, 50.00%

Other drugs people take besides Pulmicort *:

  1. Zyrtec: 1 person, 50.00%
  2. Symbicort: 1 person, 50.00%
  3. Naproxen: 1 person, 50.00%
  4. Multivitamin: 1 person, 50.00%
  5. Magnesium: 1 person, 50.00%
  6. Glucosamine: 1 person, 50.00%
  7. Famotidine: 1 person, 50.00%
  8. Calcium: 1 person, 50.00%
  9. Boswellia: 1 person, 50.00%
  10. Aspirin: 1 person, 50.00%

Other side effects people have besides Osteoarthritis *:

  1. Sinusitis (inflammation of sinus): 1 person, 50.00%
  2. Irritable Bowel Syndrome: 1 person, 50.00%
  3. Hiatal Hernia (hernia resulting from the protrusion of part of the stomach through the diaphragm): 1 person, 50.00%
  4. Allergic Rhinitis: 1 person, 50.00%

* Approximation only. Some reports may have incomplete information.

Do you take Pulmicort and have Osteoarthritis?

Check whether Osteoarthritis is associated with a drug or a condition

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Related studies

How the study uses the data?

The study is based on budesonide (the active ingredients of Pulmicort). Other drugs that have the same active ingredients (e.g. generic drugs) are considered. Dosage of drugs is not considered in the study.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: